In today’s up and down economy the old principle of buy and hold is slowly becoming an ancient artifact, as day traders have taken over using highly sophisticated chart patterns to reap gains. Though the basis of all investments should always begin with fundamental analysis, the variable which most believe is the prime factor driving [...]
Cinderella stories within the biotech industry are hard to come by these days, especially considering the difficulty of attaining FDA approval while attempting to maintain a steady balance of cash on hand. Dilution, false promises and hopes run rampant during the recent renewed financial crisis. There are, however, success stories which seem to trump the [...]
Vivus, Inc. (NASDAQ:VVUS) is a company we really like here based on fundamentals, especially considering they have $158M cash on hand to see them through to their NDA for Qnexa (Obesity) and Avanafil, of which they paid $27M to acquire. We strongly believe it will outperform the broader market, and trump any major US indices. [...]
Ever since the S&P 500 dipped below the landmark support at 1060, it has become increasingly evident that the Federal Reserve, along with hedge funds, institutions and banks have been keen on playing games with retail investors in order to stir up false hopes that a recovery may be on the way. Well, guess what, [...]
Looks like the bulls will be frying on a wooden stick via the bears bond-fire as of early morning Tuesday, June, 29, 2010, especially considering the bloody massacre that took place in our World Markets: China and Europe. Fears on the World Bank’s statement that economic growth in China would slow caused panic worldwide, and [...]
With the continued pessimism on economic outlook and future data, there currently sits no better investment on the table other than Direxion Financial Bear 3x ETF (NYSE:FAZ), and the obvious choice, Gold ETF (NYSE:GLD). While numerous reports have surfaced recently that several polled Wall Street analysts foresee a rise of 13% in the S&P 500 [...]
It seems like the Feds and their relentless pursuit of a speedy economic recovery have pointed their direction towards the mass U.S. media in order to capitalize on the slow June trading month. Major banks rallied by the bunches, with the likes of Citigroup (NYSE:C), Bank of America (NYSE:BAC), JPMorgan Chase (NYSE:JPM), Goldman Sachs (NYSE:GS), [...]
The 3x Financial Bear ETF (NYSE:FAZ) has never looked so juicy, especially with the prepped up, fake financial rally created by sleazy, lying, and manipulative US government regulators as they issued numerous, erroneous headlines in order to hide the truth from the public’s eye. Bank stocks will be the first to feel the burn as [...]
Hana Biosciences, Inc. (OTC:HNAB) Comparisons: AspenBio Pharma (NASDAQ:APPY), Somaxon (NASDAQ:SOMX), Cell Therapeutics (NASDAQ:CTIC), Delcatch Systems (NASDAQ:DCTH). * Full article requires membership, visit our subscriptions page to become a member Amidst an uncertain market, Hana Biosciences has positioned itself nicely for the upcoming ASCO conference on June, 7th, 2010, where it will present its phase 2 [...]
Discovery Laboratories, Inc. This report is on (NASDAQ:DSCO), and also includes the following companies: Johnson & Johnson (NYSE:JNJ), Merck & Co. (NYSE:MRK), Pfizer (NYSE:PFE), Somaxon (NASDAQ:SOMX), Hemispherx (AMEX:HEB), AspenBio Pharma (NASDAQ:APPY), and AEterna Zentaris (NASDAQ:AEZS). Without a doubt, this past year the biotech industry has been characterised by companies who’ve found ways to persevere past [...]
